[HTML][HTML] High frequency of antiviral resistance mutations in HBV genotypes A2 and H: multidrug resistance Strains in Mexico
Methods This cross-sectional study analyzed 158 samples. HBV DNA was extracted,
amplified, and sequenced in serum samples using the spin column method, PCR assay, and …
amplified, and sequenced in serum samples using the spin column method, PCR assay, and …
[PDF][PDF] Tenofovir disoproxil fumarate monotherapy for nucleos (t) ide analogue-naive and nucleos (t) ide analogue-experienced chronic hepatitis B patients
SK Jung, KA Kim, SY Ha, HK Lee… - Clinical and …, 2015 - synapse.koreamed.org
Background/Aims: This study investigated the antiviral effects of tenofovir disoproxil fumarate
(TDF) monotherapy in nucleos (t) ide analogue (NA)-naive and NA-experienced chronic …
(TDF) monotherapy in nucleos (t) ide analogue (NA)-naive and NA-experienced chronic …
Efficacy of Tenofovir‐Based Combination Therapy versus Tenofovir Monotherapy in Chronic Hepatitis B Patients Presenting with Suboptimal Responses to …
L Chen, X Wang, Q Zhang, J Gong… - Gastroenterology …, 2016 - Wiley Online Library
Background/Aims. It remains unclear whether tenofovir disoproxil fumarate‐(TDF‐) based
combination therapy produces better outcomes than TDF monotherapy in chronic hepatitis B …
combination therapy produces better outcomes than TDF monotherapy in chronic hepatitis B …
[PDF][PDF] Real world experience of telbivudine versus entecavir in patients with chronic Hepatitis B, including long-term outcomes after treatment modification
JW Choi, SH Kim, JH Seo, YS Cho… - Yonsei Medical …, 2018 - synapse.koreamed.org
Purpose To estimate long-term outcomes after treatment modification in patients with chronic
hepatitis B (CHB) treated with entecavir (ETV) and telbivudine (LdT). Materials and Methods …
hepatitis B (CHB) treated with entecavir (ETV) and telbivudine (LdT). Materials and Methods …
[HTML][HTML] The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy
JH Kim, SH Ahn, SY Ko, WH Choe… - Clinical and Molecular …, 2016 - ncbi.nlm.nih.gov
Methods: We retrospectively reviewed the medical records of CHB patients treated for up to
3 years with ETV-ADV combination therapy as a rescue therapy for drug resistance. In cases …
3 years with ETV-ADV combination therapy as a rescue therapy for drug resistance. In cases …
[HTML][HTML] Comparison of the efficacy of tenofovir monotherapy versus tenofovir-based combination therapy in adefovir-experienced chronic hepatitis B patients: a …
H Wang, X Lu, X Yang, Q Ning - International journal of clinical and …, 2015 - ncbi.nlm.nih.gov
Background: Chronic hepatitis B virus (HBV) infection remains a major public health
problem worldwide. Tenofovir monotherapy or tenofovir-based combination therapy have …
problem worldwide. Tenofovir monotherapy or tenofovir-based combination therapy have …
[HTML][HTML] Efficacy of peginterferon α-2a in treatment of chronic hepatitis B resistant to multiple nucleos (t) ide analogues
Y Long, Y Yang, J XueHua, C ZhiYong - 临床肝胆病杂志, 2016 - lcgdbzz.com
Objective To investigate the efficacy of peginterferon alfa-2a (PEG-IFN α-2a) in the treatment
of HBe Ag-positive chronic hepatitis B (CHB) resistant to multiple nucleos (t) ide analogues …
of HBe Ag-positive chronic hepatitis B (CHB) resistant to multiple nucleos (t) ide analogues …
聚乙二醇干扰素 α-2a 治疗多种核苷和核苷酸类药物耐药慢性乙型肝炎的效果观察
杨龙， 杨阳， 蒋雪花， 陈志勇 - 临床肝胆病杂志, 2016 - lcgdbzz.org
目的观察聚乙二醇干扰素(PEG-IFN) α-2a 治疗对多种核苷和核苷酸类药物(NAs) 耐药的HBe Ag
阳性慢性乙型肝炎(CHB) 患者的疗效. 方法选取武警上海市总队医院2009 年8 月-2014 年2 …
阳性慢性乙型肝炎(CHB) 患者的疗效. 方法选取武警上海市总队医院2009 年8 月-2014 年2 …
[PDF][PDF] 만성 B 형간염의 항바이러스 치료에서 구제요법으로서 테노포비어 단독치료의 가능성
김창욱 - 대한소화기학회지, 2015 - synapse.koreamed.org
B 형 간염바이러스에 대한 경구용 항바이러스 제제가 개발되어 1999 년부터 우리나라에서
라미부딘이 사용된 이후 만성 B 형간염의 치료는 획기적 발전을 이루었다. 1, 2 특히, 최근 …
라미부딘이 사용된 이후 만성 B 형간염의 치료는 획기적 발전을 이루었다. 1, 2 특히, 최근 …
[ЦИТИРОВАНИЕ][C] 富马酸替诺福韦二吡呋酯单药治疗拉米夫定耐药慢性乙型肝炎的疗效观察
戚敬虎， 鞠金昌， 徐雷， 张囡囡， 陈斌 - 中华肝脏病杂志, 2016